Effect of Virtual Reality on Prostaglandin Levels in Adolescent Females With Primary Dysmenorrhea

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-05-25

Study Completion Date

2025-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will be conducted to study the effect of virtual reality therapy on prostaglandin levels in adolescent females with primary dysmenorrhea.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Impact of Virtual Reality on Painful Menstruation

NCT06961396

Painful Menstruation Relaxation; Back Ligaments

RECRUITING NA

Using Virtual Reality (VR) Technology in Gynecological and Obstetrics Procedures

NCT05941390

Virtual Reality Anxiety Pain

UNKNOWN NA

Virtual Reality-Based Relaxation and Exergaming vs. Traditional Relaxation for Primer Dysmenorrhea

NCT06728306

Primary Dysmenorrhea

COMPLETED NA

VR Headset for Pain During Pregnancy Termination

NCT06029582

Pregnancy Termination

UNKNOWN NA

Virtual Reality for Anxiety and Pain Management in Transvaginal Ultrasound for Endometriosis

NCT07328061

Endometriosis

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Primary dysmenorrhea is thought to be caused by excessive levels of prostaglandins, which are hormones that stimulate the uterus to contract during menstruation and childbirth, Treatment must be tailored to individual patient symptoms. Pharmacologic management with non-steroidal anti-inflammatory medications and/or combined hormonal contraceptives is most common. Heat therapy, exercise, vitamins and dietary supplements have limited evidence and can be offered for patients seeking non-pharmacologic adjunctive or alternative options. Greater awareness for both health-care providers and patients allow for early intervention to reduce impact on quality of life and life course potential. The significance of this study to assess the effect of virtual reality therapy on primary dysmenorrhea.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Primary Dysmenorrhea

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Pharmacological treatment

It will consist of 25 girls, who will receive pharmacological treatment in the form of ibuprofen 400 mg, three times per day, during the first 2 days of menstruation, for 3 menstrual cycles.

Group Type OTHER

Pharmacological treatment

Intervention Type DRUG

All participants in the two groups will receive pharmacological treatment in the form of ibuprofen 400 mg, three times per day, during the first 2 days of menstruation, for 3 menstrual cycles.

Virtual reality + Pharmacological treatment

It will consist of 25 girls, who will receive the same pharmacological treatment in addition to virtual reality during the first 2 days of menstruation, for 3 menstrual cycles.

Group Type EXPERIMENTAL

Pharmacological treatment

Intervention Type DRUG

All participants in the two groups will receive pharmacological treatment in the form of ibuprofen 400 mg, three times per day, during the first 2 days of menstruation, for 3 menstrual cycles.

Virtual reality

Intervention Type OTHER

The experimental group will receive virtual reality during the first 2 days of menstruation, for 3 menstrual cycles.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Pharmacological treatment

All participants in the two groups will receive pharmacological treatment in the form of ibuprofen 400 mg, three times per day, during the first 2 days of menstruation, for 3 menstrual cycles.

Intervention Type DRUG

Virtual reality

The experimental group will receive virtual reality during the first 2 days of menstruation, for 3 menstrual cycles.

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Ibuprofen (400 mg)

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 17- 21 years old.
* The body mass index (BMI) \< 30 kg/m2.
* Unmarried females.
* Females with dysmenorrhea pain.
* Females with regular menstrual cycles.
* Females with normal gynecology.

Exclusion Criteria

* Have a pathological disease related to reproduction.
* Students who use analgesic drugs for 3 months/3 menstrual cycles.
* Students with menstrual pain secondary to diagnosed organic or inflammatory causes.

Minimum Eligible Age

17 Years

Maximum Eligible Age

21 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No